The most engaging conversation between health professionals happens in chance meetings in the hallways. During these moments so much is learned .*One Thing* brings together thought leaders in conversation and we share it with health enthusiasts , practitioners, and learners. Our conversations primar...
What happens when all your supplements, clean eating, and protocols stop working—and you just keep getting sicker? Danielle Pashko had built her career in functional medicine, doing everything “right.” But after thyroid cancer, Lyme disease, and long COVID wrecked her health, she hit a wall. Not…
In this episode of The One Thing Podcast, Dr. Sarah Nasir shares her visionary approach to treating addiction through a deeply integrative and compassionate lens. As an osteopathic physician and founder of Zara Care, she is reshaping addiction recovery by combining primary care with holistic healin…
In this episode, Dr. Adam Rinde welcomes back microbiologist and PolyBio Research Foundation co-founder Dr. Amy Proal. Together, they unravel a framework for understanding chronic illnesses through the lens of persistent infections and their impact on mitochondria, immunity, and neurological health…
This week on The One Thing Podcast, host Dr. Adam Rinde welcomes back renowned rheumatologist Dr. Aly Cohen to dive deep into her groundbreaking new book, "Detoxify" (releasing May 2025!). Forget extreme deprivation and unsustainable measures. Dr. Cohen shares her balanced, practical, and scienc…
In this episode, Dr. Adam Rinde sits down with integrative medicine specialist Dr. Carla Kuon from University of California San Francisco (UCSF) to explore the latest insights into long COVID, chronic fatigue syndrome, and post-viral illnesses. Dr. Kuon shares powerful breakthroughs from her clinic…
In this episode of The One Thing Podcast, Dr. Adam Rinde and Dr. Paul Anderson discuss a powerful concept shaping chronic illness care: the Cell Danger Response (CDR). If you or someone you know is dealing with persistent fatigue, inflammation, long COVID, or autoimmune challenges, this discussi…